Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 3
1984 3
1985 4
1986 10
1987 2
1988 3
1989 4
1990 6
1991 3
1992 3
1993 10
1994 8
1995 10
1996 6
1997 4
1998 5
1999 2
2000 2
2001 5
2002 3
2003 3
2004 3
2005 6
2006 4
2007 3
2008 9
2009 9
2010 8
2011 10
2012 14
2013 9
2014 13
2015 12
2016 5
2017 7
2018 6
2019 5
2020 11
2021 6
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group. Grothey A, et al. Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177514 Clinical Trial.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
[Nutrition in liver cirrhosis].
Gundling F, Teich N, Strebel HM, Schepp W, Pehl C. Gundling F, et al. Among authors: schepp w. Med Klin (Munich). 2007 Jun 15;102(6):435-44. doi: 10.1007/s00063-007-1056-x. Med Klin (Munich). 2007. PMID: 17571218 Review. German.
[Hepatogenous diabetes - diagnostics and treatment].
Gundling F, Schumm-Draeger PM, Schepp W. Gundling F, et al. Among authors: schepp w. Z Gastroenterol. 2009 May;47(5):436-45. doi: 10.1055/s-0028-1109200. Epub 2009 May 5. Z Gastroenterol. 2009. PMID: 19418413 Review. German.
[Consensus conference of the DGVS on gastroesophageal reflux].
Koop H, Schepp W, Müller-Lissner S, Madisch A, Micklefield G, Messmann H, Fuchs KH, Hotz J. Koop H, et al. Among authors: schepp w. Z Gastroenterol. 2005 Feb;43(2):163-4. doi: 10.1055/s-2005-857870. Z Gastroenterol. 2005. PMID: 15700206 Review. German. No abstract available.
226 results